Conclusion: Considering primary nodes' co-primary efficacy outcomes and head-to-head comparisons, efficacy for sialorrhea is most consistent for the following agents, decreasing from metoclopramide through cyproheptadine, sulpiride, propantheline, diphenhydramine, benzhexol, doxepin, amisulpride, chlorpheniramine, to amitriptyline, and atropine (the latter not for nocturnal sialorrhea). Shared decision-making with the patient should guide treatment decisions regarding clozapine-related sialorrhea.
PubMed 37821573 ↗Diphenhydramine
The short answer. Most people who report on Diphenhydramine say it did not help (only 37% of 79 positive). It is most often used for sleep: 85% of 59 reports say that improved. It is well studied — 57 meta-analyses on PubMed. The most common complaint is drowsiness.
From 116 mentions in total — the rest didn't say how it went and aren't counted.
What Diphenhydramine does, according to users
Of the people who reported each effect, the share who said it got better.
4 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 57 meta-analyses on PubMed ↗ · 298 randomized trials ↗
Conclusion: The addition of corticosteroids to an antihistamine as treatment for AU needs to be further investigated. Well-designed, high-quality interventional trials are needed to establish evidence-based treatment guidelines for AU.
PubMed 38420865 ↗Conclusion: Although PHGS is a disease with a high worldwide prevalence, the lack of consensus about therapeutic management indicates gaps in existing evidence. Most of the proposed treatment consists in symptomatic drugs with empiric regimens which are ineffective for the viral replication. The main limit to realize randomized clinical trial is due to the rapid onset and remission of the disease. In fact, the diagnostic delay, estimated in 72 h, decreases the effectiveness of any antiviral drugs.
PubMed 37733027 ↗Conclusion: The studies in this review suggest hydroxyzine could be considered as a short-term treatment option for adults with insomnia for whom previous therapy was ineffective, not tolerated, or contraindicated. Additional long-term studies with an active comparator are needed to further establish its role in insomnia treatment.
PubMed 36843057 ↗1,255 human trials on ClinicalTrials.gov test Diphenhydramine — 792 completed, 75 recruiting now. See all on ClinicalTrials.gov ↗
- Clinical Study Evaluating the Effect of Losartan · Pancreatic Cancer · 2026
- Effects of Kudzu Root (Gegen) on Drug-Metabolizing Enzymes and Blood Clotting in Healthy Volunteers · Herb-drug Interactions · 2023
- The Effect of Losartan on Cephalexin · Possible Interaction Between Losartan and Cephalexin, Healthy · 2026
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
The current US prescription label has no boxed warning.
The FDA found Diphenhydramine as an undeclared ingredient in 1 product sold as supplements, most recently on 2019-01-28. FDA tainted-products database ↗
22 recalls of products named for Diphenhydramine. Most recent:
- 2025-01-22 · Class III: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID. record ↗
- 2023-05-31 · Class II: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile. record ↗
- 2023-02-22 · Class II: Lack of sterility assurance record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
166,253 adverse-event reports mention Diphenhydramine. Most often reported:
- Off label use · 18,011
- Fatigue · 15,985
- Nausea · 14,283
- Headache · 13,765
- Pain · 11,759
- Drug ineffective · 11,497
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Diphenhydramine E — an unlikely cause of liver injury. LiverTox entry ↗
NIH has funded 6 research projects with Diphenhydramine in the title, $225,501 in total (1985–2009). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Diphenhydramine ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Benadryl works the best when there is nothing else I can do and I take it a lot but probably not the best way to get sleep.”
“i can't sleep at all when i take that stuff. Makes me paranoid.”
“I hate to rely on it, but our old friend Benadryl works pretty well.”
“Had insomnia and tested out a Benadryl and trazadone. Felt weird and nervous but it let me sleep at least.”
Top discussions (5)
- I just want to be able to sleep. SOS ↗
- Sleep stack that does not help after quitting marijuana insomnia. ↗
- Is there anything you guys recommend when you simply cannot fall asleep? ↗
- Cerebral Health Pyritinol Test Results (WARNING) ↗
- If you have brain fog or lots of mental focus issues you might just need allergy meds ↗
Diphenhydramine compared
Other options for sleep
Sources
- User reports: 116 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- FDA tainted-products database ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate